Effect of pre-S1 antigen on human lymphocyte proliferative responses

被引:1
作者
Sulowska, Z
Dworniak, D
Tchorzewski, H
Zeman, K
Sidorkiewicz, M
机构
[1] MIL MED ACAD,DEPT INFECT DIS & GASTROENTEROL,PL-91347 LODZ,POLAND
[2] MIL MED ACAD,INST BASIC MED SCI,DEPT PATHOPHYSIOL & IMMUNOL,PL-90647 LODZ,POLAND
[3] MED SCH,INST PHYSIOL & BIOCHEM,DEPT BIOCHEM 1,PL-90131 LODZ,POLAND
关键词
hepatitis B virus (HBV); hepatitis B surface antigen (HBsAg); mixed lymphocyte reaction (MLR); phytohemagglutinin (PHA); lymphocyte subsets;
D O I
10.1016/0165-2478(95)02457-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The peripheral blood mononuclear cells (PBMCs) from patients acutely infected with HBV and recovered completely (n = 20), patients with chronic hepatitis B infection-(CHB)(n = 10) and HBsAg-positive carriers (n = 9) and healthy individuals (n = 8) were studied for their in vitro proliferative response to a synthetic Pre-S1(20-49)x4 antigen. PBMCs from convalescents showed significant proliferative response in the presence of synthetic Pre-S1 antigen, PBMCs from CHB- and HBsAg-positive exhibited reduced proliferative response not only to Pre-S1 antigen but also to nonspecific mitogens. This study suggests that the immune recognition of Pre-S1 antigen and response of PBMCs to the Pre-S1 antigen may be an important part of the normal human response to HBV infection, Failure to clear the HBV infection with development of the chronic carrier state may be caused by the lack of an efficient pre-S1 antigen-specific response.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 24 条
  • [1] ALBERTI A, 1990, SPRINGER SEMIN IMMUN, V12, P5
  • [2] BARNABA V, 1983, CLIN EXP IMMUNOL, V53, P281
  • [3] ANTI-PRE-S RESPONSES AND VIRAL CLEARANCE IN CHRONIC HEPATITIS-B VIRUS-INFECTION
    BUDKOWSKA, A
    DUBREUIL, P
    POYNARD, T
    MARCELLIN, P
    LORIOT, MA
    MAILLARD, P
    PILLOT, J
    [J]. HEPATOLOGY, 1992, 15 (01) : 26 - 31
  • [4] CELIS E, 1988, J IMMUNOL, V140, P1808
  • [5] HEPATITIS-B VIRUS STRUCTURE AND BIOLOGY
    CHISARI, FV
    FERRARI, C
    MONDELLI, MU
    [J]. MICROBIAL PATHOGENESIS, 1989, 6 (05) : 311 - 325
  • [6] CELLULAR RECOGNITION AND HLA RESTRICTION OF A MIDSEQUENCE HBSAG PEPTIDE IN HEPATITIS-B VACCINATED INDIVIDUALS
    DEULOFEUT, H
    IGLESIAS, A
    MIKAEL, N
    BING, DH
    AWDEH, Z
    YUNIS, J
    MARCUSBAGLEY, D
    KRUSKALL, MS
    ALPER, CA
    YUNIS, EJ
    [J]. MOLECULAR IMMUNOLOGY, 1993, 30 (10) : 941 - 948
  • [7] FERRARI C, 1990, J IMMUNOL, V145, P3442
  • [8] THE PRES1 ANTIGEN OF HEPATITIS-B VIRUS IS HIGHLY IMMUNOGENIC AT THE T-CELL LEVEL IN MAN
    FERRARI, C
    PENNA, A
    BERTOLETTI, A
    CAVALLI, A
    VALLI, A
    SCHIANCHI, C
    FIACCADORI, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) : 1314 - 1319
  • [9] FINE SPECIFICITY OF THE HUMAN T-CELL RESPONSE TO THE HEPATITIS-B VIRUS PRES1 ANTIGEN
    FERRARI, C
    CAVALLI, A
    PENNA, A
    VALLI, A
    BERTOLETTI, A
    PEDRETTI, G
    PILLI, M
    VITALI, P
    NERI, TM
    GIUBERTI, T
    FIACCADORI, F
    [J]. GASTROENTEROLOGY, 1992, 103 (01) : 255 - 263
  • [10] FUNCTIONAL-ANALYSIS OF PERIPHERAL-BLOOD LYMPHOCYTES ISOLATED FROM PATIENTS WITH CHRONIC HEPATITIS TYPE-B
    GARCIAMONZON, C
    MORENOOTERO, R
    GARCIABUEY, L
    LOPEZBOTET, M
    DELANDAZURI, MO
    SANCHEZMADRID, F
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (01) : 73 - 78